Applied Biologics LLC, an integrated biotechnology company engaged in the development and commercialization of innovative biologic products derived from the placental tissues, is pleased to announce that Applied Biologics has been awarded a GSA Schedule 20 contract and is now certified to provide goods and services to the Federal government on a national scale.
Acknowledging the growth in federal spending through the General Services Administration (GSA), Applied Biologics has placed their biomedical platform of placental tissue-derived products on the government’s electronic ordering system, GSA Advantage!®.
“As a Veteran-owned small business, Applied Biologics has been working closely with numerous VA Medical Centers and Department of Defense (DoD) installations since 2011. This schedule opens up significantly more markets throughout the country and simplifies the purchasing process for the procurement officers,†states Edward Britt, President at Applied Biologics. He continues: “Being on the GSA schedule expands our opportunity to reach VA Medical Centers, and DoD installations across the contiguous 48 states, HI, AK and Puerto Rico, as they can now take advantage of our fixed government pricing on our innovative placental tissue-derived products, including FloGraft® and XWRAP® in the management of Chronic Wounds, Sports Medicine, Spine Surgery, OB/GYN, Dental and Ocular Wound Management and a myriad of other medically-related utilization.â€
Surgeons, physicians and caregivers across the nation find that Applied Biologics products fit organically into their current standard of care by delivering innovative allograft to manage difficult-to-heal wounds, sports injuries, open spine procedures, OB/GYN and urological procedures, and nerve ligament and tendon defects. This newly awarded GSA Schedule Contract, better positions those providers to service the public sector’s needs. Applied Biologics continues to provide FloGraft® and XWRAP® to our commercial customers through our vast network of channel partners and distribution network.
SOURCE Applied Biologics LLC